138 related articles for article (PubMed ID: 7895514)
1. Mutations in the coding region of c-myc occur independently of mutations in the regulatory regions and are predominantly associated with myc/Ig translocation.
Bhatia K; Spangler G; Hamdy N; Neri A; Brubaker G; Levin A; Magrath I
Curr Top Microbiol Immunol; 1995; 194():389-98. PubMed ID: 7895514
[TBL] [Abstract][Full Text] [Related]
2. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
Ambinder RF; Griffin CA
Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
[TBL] [Abstract][Full Text] [Related]
3. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.
Joos S; Falk MH; Lichter P; Haluska FG; Henglein B; Lenoir GM; Bornkamm GW
Hum Mol Genet; 1992 Nov; 1(8):625-32. PubMed ID: 1301171
[TBL] [Abstract][Full Text] [Related]
4. Illegitimate recombinations between c-myc and immunoglobulin loci are remodeled by deletions in mouse plasmacytomas but not in Burkitt's lymphomas.
Müller JR; Janz S; Potter M
Curr Top Microbiol Immunol; 1995; 194():425-9. PubMed ID: 7895518
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus and Burkitt's lymphoma.
Magrath I; Jain V; Bhatia K
Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
[TBL] [Abstract][Full Text] [Related]
6. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
7. Selective expression of one c-myc allele in two human myeloma cell lines.
Kuehl WM; Brents LA; Chesi M; Bergsagel PL
Cancer Res; 1996 Oct; 56(19):4370-3. PubMed ID: 8813127
[TBL] [Abstract][Full Text] [Related]
8. [Molecular analysis in Argentinian patients with Burkitt's lymphoma].
Gutiérrez MI; Barriga F; Díez B; Larripa I; Magrath I
Sangre (Barc); 1990 Feb; 35(1):10-4. PubMed ID: 2159189
[TBL] [Abstract][Full Text] [Related]
9. Application of long-distance polymerase chain reaction to detection of junctional sequences created by chromosomal translocation in mature B-cell neoplasms.
Akasaka T; Muramatsu M; Ohno H; Miura I; Tatsumi E; Fukuhara S; Mori T; Okuma M
Blood; 1996 Aug; 88(3):985-94. PubMed ID: 8704258
[TBL] [Abstract][Full Text] [Related]
10. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
11. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
[TBL] [Abstract][Full Text] [Related]
12. Intraclonal molecular heterogeneity suggests a hierarchy of pathogenetic events in Burkitt's lymphoma.
Gutiérrez MI; Bhatia K; Cherney B; Capello D; Gaidano G; Magrath I
Ann Oncol; 1997 Oct; 8(10):987-94. PubMed ID: 9402172
[TBL] [Abstract][Full Text] [Related]
13. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
Bhatia K; Huppi K; Spangler G; Siwarski D; Iyer R; Magrath I
Nat Genet; 1993 Sep; 5(1):56-61. PubMed ID: 8220424
[TBL] [Abstract][Full Text] [Related]
14. Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.
Avet-Loiseau H; Gerson F; Magrangeas F; Minvielle S; Harousseau JL; Bataille R;
Blood; 2001 Nov; 98(10):3082-6. PubMed ID: 11698294
[TBL] [Abstract][Full Text] [Related]
15. t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia.
Liu D; Shimonov J; Primanneni S; Lai Y; Ahmed T; Seiter K
Mol Cancer; 2007 Jun; 6():35. PubMed ID: 17547754
[TBL] [Abstract][Full Text] [Related]
16. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association.
Shiramizu B; Barriga F; Neequaye J; Jafri A; Dalla-Favera R; Neri A; Guttierez M; Levine P; Magrath I
Blood; 1991 Apr; 77(7):1516-26. PubMed ID: 1849033
[TBL] [Abstract][Full Text] [Related]
17. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
Müller JR; Janz S; Potter M
Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
[TBL] [Abstract][Full Text] [Related]
18. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
Bemark M; Neuberger MS
Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
[TBL] [Abstract][Full Text] [Related]
19. Localization of breakpoints by polymerase chain reactions in Burkitt's lymphoma with 8;14 translocations.
Shiramizu B; Magrath I
Blood; 1990 May; 75(9):1848-52. PubMed ID: 2110009
[TBL] [Abstract][Full Text] [Related]
20. Application of long PCR to detect t(8;14)(q24;q32) translocations in childhood Burkitt's lymphoma and B-ALL.
zur Stadt U; Hoser G; Reiter A; Welte K; Sykora KW
Ann Oncol; 1997; 8 Suppl 1():31-5. PubMed ID: 9187426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
